Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish(R) Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish(R) Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.
The Malaysian Reserve

Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer

Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor ...